|
General Information
|
|
|
Product
|
MURF1 Peptide
|
|
Description
|
Antigenic Blocking Peptide E3 ubiquitin-protein ligase TRIM 63 Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken wtihin amino acid region 270-310 on human MURF1 protein.
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q969Q1
|
|
Overview
|
E3 ubiquitin ligase,Regulates the proteasomal degradation of muscle proteins under amino acid starvation, where muscle protein is catabolized to provide other organs with amino acids.
|
|
Molecular Function
|
ligase activity;ubiquitin-protein transferase activity
|
|
Subcellular Location
|
Cytoplasm, Nucleus
|
|
Expression
|
Muscle specific. Selectively expressed in heart and skeletal muscle. Also expressed in the iris
|
|
Structure
|
Homodimer. Homooligomer and heterooligomer
|
|
Alternative Nomenclature
|
E3 ubiquitin-protein ligase TRIM63 antibody
IRF antibody
MURF 1 antibody
MURF2 antibody
RNF 28 antibody
SMRZ antibody
TRIM63 antibody
Ubiquitin ligase TRIM63 antibody
|
| |
|
MURF1 Antibody
MURF1 Antibody FITC
MURF1 Antibody BIOTIN
MURF1 Positive Control
